Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1961 Aug 19;85(8):414–419.

The Effect of Dosage Form upon the Gastrointestinal Absorption Rate of Salicylates *

Gerhard Levy, R H Gumtow, J M Rutowski
PMCID: PMC1848263  PMID: 13761602

Full text

PDF
414

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BRODIE B. B., HOGBEN C. A. Some physico-chemical factors in drug action. J Pharm Pharmacol. 1957 Jun;9(6):345–380. doi: 10.1111/j.2042-7158.1957.tb12289.x. [DOI] [PubMed] [Google Scholar]
  2. BROH-KAHN R. H. Choline salicylate: a new, effective, and well-tolerated analgesic, anti-inflammatory, and antipyretic agent. Int Rec Med. 1960 Apr;173:217–233. [PubMed] [Google Scholar]
  3. LEVY G., HAYES B. A. Physicochemical basis of the buffered acetylsalicylic acid controversy. N Engl J Med. 1960 May 26;262:1053–1058. doi: 10.1056/NEJM196005262622102. [DOI] [PubMed] [Google Scholar]
  4. WEIKEL J. H., Jr, LISH P. M. Gastrointestinal pharmacology of antipyretic-analgetic agents. II. Absorption and smooth muscle effects. Arch Int Pharmacodyn Ther. 1959 Apr 1;119(3-4):398–408. [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES